Lv1
48 积分 2025-01-02 加入
Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease
5小时前
已完结
Total bilirubin modified the association between diabetes and stroke: a cross-sectional study from NHANES 2011–2016
2天前
已完结
Tirzepatide Once Weekly for the Treatment of Obesity
3个月前
已关闭
Tirzepatide for Obesity Treatment and Diabetes Prevention
3个月前
已完结
Obesity and dyslipidemia in early life: Impact on cardiometabolic risk
3个月前
已完结
Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis
3个月前
已完结
Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart Failure
3个月前
已完结
Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus
3个月前
已完结
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
3个月前
已完结
Obesity and the kidney: mechanistic links and therapeutic advances
3个月前
已完结
皖公网安备34019202002308
